Literature DB >> 22159250

The effect of season of operation on the survival of patients with resected non-small cell lung cancer.

Akif Turna1, Atilla Pekçolaklar, Muzaffer Metin, Ilhan Yaylim, Atilla Gurses.   

Abstract

Stage has been defined as the major prognostic factor in resected non-small cell lung cancer (NSCLC). However, there is some evidence that indicates season of operation could play a role in the survival of patients. Between January 1995 and June 2008, 698 (621 men and 77 women) patients who had undergone pulmonary resection for NSCLC were evaluated. Patients were analysed according to surgical-pathological stages and month of the year in which they were operated. Vitamin D receptor (VDR) polymorphism was also analysed in 62 patients. The median survival time in all patients was 60 ± 6 months (95% confidence interval (CI): 44-81 months). The survival of patients who underwent resection in winter was statistically significantly shorter than those operated in summer (P = 0.03). When patients were analysed according to T, N and season, resection time of the year was calculated to be an independent determinant of survival (P = 0.04). A VDR genotype was also associated with better prognosis (P = 0.04). Season of the operation, VDR polymorphism and N status seemed to have independent effects on survival of operated NSCLC patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22159250      PMCID: PMC3279971          DOI: 10.1093/icvts/ivr063

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  15 in total

1.  Association of A vitamin D receptor polymorphism with sporadic breast cancer development.

Authors:  J E Curran; T Vaughan; R A Lea; S R Weinstein; N A Morrison; L R Griffiths
Journal:  Int J Cancer       Date:  1999-12-10       Impact factor: 7.396

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Revisions in the International System for Staging Lung Cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

4.  Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients.

Authors:  Wei Zhou; Rebecca Suk; Geoffrey Liu; Sohee Park; Donna S Neuberg; John C Wain; Thomas J Lynch; Edward Giovannucci; David C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

5.  Seasonal variation influences outcomes following lung cancer resections.

Authors:  Damien J LaPar; Alykhan S Nagji; Castigliano M Bhamidipati; Benjamin D Kozower; Christine L Lau; Gorav Ailawadi; David R Jones
Journal:  Eur J Cardiothorac Surg       Date:  2010-12-18       Impact factor: 4.191

6.  An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation.

Authors:  William B Grant
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

7.  Cancer survival is dependent on season of diagnosis and sunlight exposure.

Authors:  Hyun-Sook Lim; Rahul Roychoudhuri; Julian Peto; Gary Schwartz; Peter Baade; Henrik Møller
Journal:  Int J Cancer       Date:  2006-10-01       Impact factor: 7.396

8.  Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis.

Authors:  P Selvaraj; G Chandra; M S Jawahar; M Vidya Rani; D Nisha Rajeshwari; P R Narayanan
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

9.  Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation.

Authors:  C L Hanchette; G G Schwartz
Journal:  Cancer       Date:  1992-12-15       Impact factor: 6.860

10.  Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway).

Authors:  Trude Eid Robsahm; Steinar Tretli; Arne Dahlback; Johan Moan
Journal:  Cancer Causes Control       Date:  2004-03       Impact factor: 2.506

View more
  7 in total

1.  Seasonal variation influences outcomes following lung cancer resections.

Authors:  Damien J LaPar; Alykhan S Nagji; Castigliano M Bhamidipati; Benjamin D Kozower; Christine L Lau; Gorav Ailawadi; David R Jones
Journal:  Eur J Cardiothorac Surg       Date:  2010-12-18       Impact factor: 4.191

2.  Association of vitamin D receptor FokI and ApaI polymorphisms with lung cancer risk in Tunisian population.

Authors:  Wajih Kaabachi; Safa Kaabachi; Ahlem Rafrafi; Amira Ben Amor; Kalthoum Tizaoui; Faycal Haj Sassi; Kamel Hamzaoui
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

Review 3.  The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis.

Authors:  P G Vaughan-Shaw; F O'Sullivan; S M Farrington; E Theodoratou; H Campbell; M G Dunlop; L Zgaga
Journal:  Br J Cancer       Date:  2017-03-16       Impact factor: 7.640

4.  Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer.

Authors:  Laura Elena Pineda Lancheros; Cristina Pérez Ramírez; Almudena Sánchez Martín; José María Gálvez Navas; Fernando Martínez Martínez; María Del Carmen Ramírez Tortosa; Alberto Jiménez Morales
Journal:  Nutrients       Date:  2021-10-25       Impact factor: 5.717

5.  Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model.

Authors:  Magdalena Milczarek; Mateusz Psurski; Andrzej Kutner; Joanna Wietrzyk
Journal:  BMC Cancer       Date:  2013-06-18       Impact factor: 4.430

Review 6.  Vitamin D deficiency and the lung: disease initiator or disease modifier?

Authors:  Rachel E Foong; Graeme R Zosky
Journal:  Nutrients       Date:  2013-07-26       Impact factor: 5.717

7.  Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.

Authors:  Xiayu Wu; Jiaoni Cheng; Kaiyun Yang
Journal:  Int J Mol Sci       Date:  2016-09-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.